ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1851

Exploring the Relationship of Anti-Tumor Necrosis Factor Drugs and Methicillin Resistant Staphylococcus Aureus Nasal Colonization in Patients with Rheumatologic Conditions and Psoriasis

Daniel E. Kreutz1, Santosh P. Reddy1, Guy P. Fiocco2, Colleen Colbert3 and Juhee Song4, 1Internal Medicine, Scott & White Healthcare/Texas A&M University, Temple, TX, 2Division of Rheumatology, Scott & White Clinic, Temple, TX, 3Graduate Education, Scott & White Healthcare/Texas A&M University, Temple, TX, 4Statistics, Scott & White Healthcare/Texas A&M University, Temple, TX

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), psoriatic arthritis and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Session Title: Epidemiology and Health Services Research: Rheumatic Disease Pharmacoepidemiology

Session Type: Abstract Submissions (ACR)

Background/Purpose: Infection with methicillin-resistant Staphylococcus aureus (MRSA) is a source of significant morbidity/mortality.  Health-care entities spend large amounts to prevent spread of MRSA.  Most MRSA colonization literature is for surgical inpatients, with little exploration of the possible influence of immune-modifying drugs on colonization.  These drugs are being used more commonly in treatment of chronic conditions, such as rheumatologic diagnoses.  This study attempted to identify the influence of Tumor Necrosis Factor inhibitor (anti-TNF) drugs on MRSA carrier state in patients with diagnoses of psoriasis, psoriatic arthritis, rheumatoid arthritis, or ankylosing spondylitis.

Colonization with MRSA leads to greater risk of infection with MRSA.  Screening and intervention decrease blood borne infections, leading to use of screening programs.  Studies in various environments have attempted to describe the carriage rate for MRSA, now estimated to be 1.2- 14%.

There has been some investigation into the relationship between MRSA colonization and immunosuppression, but it has been limited to transplant patients, cancer patients, and those with HIV.  Currently there are no data on the relationship between immunosuppresive drugs and MRSA colonization in those being treated for rheumatologic conditions and psoriasis.

Methods: Medical records of patients admitted to two large referral hospitals between 1/1/07 and 3/31/10 were reviewed. All admitted patients 18 years and older with psoriasis, psoriatic arthritis, rheumatoid arthritis, or ankylosing spondylitis during this period were included for retrospective chart review (1001 persons).  Of these, 436 were screened for nasal MRSA during the study period.  Demographics, comorbidities and length of stay were noted as was information on treatment of their conditions and MRSA screen result.  The rate in this group was compared to known MRSA rate for all patients screened in the two hospitals for the period (6.7%).

Results: Records from 436 patients were used; 10 (2.3%) had psoriatic arthritis, 15 (3.4%) had ankylosing spondylitis, 72 (16.5%) had psoriasis, and 341 (78.2%) had rheumatoid arthritis.  MRSA colonization was noted for 53 (12.2%) patients, which is much higher than the overall rate of 6.7% for adults.  A TNF inhibitor was in the medical regimen for 54 (12.4%) patients. Of those prescribed anti-TNF drugs, 11.1% were MRSA positive.  The study population with MRSA tended to have a longer length of stay (p = 0.0529), and come from a nursing home (27.5%).  There was a strong association between nursing home residence and MRSA result (p = 0.0003).

Conclusion: Patients with psoriasis and rheumatologic conditions had a higher rate of MRSA colonization than the general patient population at these referral centers.  Patients treated with anti-TNF drugs were no more likely than those being treated with traditional immune modulating agents to have a positive MRSA screen.  Those patients coming to the hospital from a nursing facility were more likely to have a positive MRSA screen.


Disclosure:

D. E. Kreutz,
None;

S. P. Reddy,
None;

G. P. Fiocco,
None;

C. Colbert,
None;

J. Song,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exploring-the-relationship-of-anti-tumor-necrosis-factor-drugs-and-methicillin-resistant-staphylococcus-aureus-nasal-colonization-in-patients-with-rheumatologic-conditions-and-psoriasis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies